CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Activity

26 hedge funds and large institutions have $23.9M invested in Cellectar Biosciences in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.

Holders
26
Holders Change
+6
Holders Change %
+30%
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
8
Increased
7
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RA
1
Rosalind Advisors
Ontario, Canada
$5.56M
2
ACM
2
ADAR1 Capital Management
Texas
$3.82M
3
NCM
3
Nantahala Capital Management
Connecticut
$3.74M
4
ACM
4
AIGH Capital Management
Maryland
$5.31M
5
WVP
5
Worth Venture Partners
New Jersey
$1.92M

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$0
2
Wealth Enhancement Advisory Services
2
Wealth Enhancement Advisory Services
Minnesota
$0
3
TRCT
3
Tower Research Capital (TRC)
New York
$10.2K
4
UBS Group
4
UBS Group
Switzerland
$3.32K
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$50
Name Market Value Shares Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
$44 16 +16 New
Renaissance Technologies
27
Renaissance Technologies
New York
– – -21,690 Closed
Wealth Enhancement Advisory Services
28
Wealth Enhancement Advisory Services
Minnesota
– – -12,000 Closed
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
1
2